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We report on the detection of inactivation of virus particles using femtosecond laser radiation by measuring 
the conductance of a solid state nanopore designed for detecting single virus particles. Conventional methods 
of assaying for viral inactivation based on plaque forming assays require 24-48 hours for bacterial growth. 
Nanopore conductance measurements provide information on morphological changes at a single virion level. 
We show that analysis of a time series of nanopore conductance can quantify the detection of inactivation, 
requiring only a few minutes from collection to analysis. Morphological changes were verified by Dynamic 
Light Scattering (DLS).  Statistical analysis maximizing the information entropy provides a measure of the 
Log-reduction value.  Taken together, our work provides a rapid method for assaying viral inactivation with 
femtosecond lasers using solid-state nanopores. 
   
I. INTRODUCTION 
 Existing and emerging viruses are a major threat to 
human and veterinary public health. The need for safe and 
reliable inactivation or removal of viruses is universal in 
antiviral therapies, pharmaceuticals, and viral vaccine 
development. Conventional pharmaceutical pathogen 
inactivation methods are quite effective, but they involve 
substantial collateral damage and have undesirable side 
effects. [1-3] Chemical-free viral inactivation methods such 
as ultraviolet (UV) and gamma-irradiation have been used to 
minimize some of the side-effects. Unfortunately, these 
methods still adversely affect thermolabile compounds and 
denature biomolecules of interest in the medium containing 
the virus. Ultrashort Pulsed lasers (USP) provide new 
opportunities for chemical-free pathogen disinfection in 
solution. Photonic methods have the potential to provide an 
attractive alternative to existing biocides and ionizing 
radiation techniques. [4-8] Photonic inactivation has been 
successfully achieved with the focused femtosecond (fs) 
laser pulses for exposure times of ≥ 1h on sample volumes 
typically of ≤2 ml. [4-7,9,10] Although the ultrafast laser 
inactivation method for viral inactivation is fairly well 
established, a systematic understanding of the inactivation 
                                                            
^ Current address of C. Gillespie: Immunogen, 830 Winter St Waltham MA 
* wanunu@neu.edu and shyam@bu.edu 
mechanism, which can contribute to the design and 
optimization of protocols, is currently lacking. 
Viral inactivation is a complicated process and its 
outcome highly depends on the specific treatment method. A 
wide range of biological assays could detect and quantify 
intact viruses in an ensemble manner which is extremely 
laborious, time-consuming, and low-sensitive. [11] A 
different approach is to explore viruses at the single virion 
level. Different optical methods have been developed to 
characterize single virus; [12-14] but still there is a need for 
a technique that is fast, sensitive and uses low sample 
volumes. Although imaging techniques, such as AFM and 
TEM, are capable of characterizing viruses with high 
sensitivity, results will be inevitably affected by the tedious 
and costly sample preparation steps. Nanometer-sized pores 
in a membrane offer the capability of electrically detecting 
molecules in a label-free manner at single-molecule level in 
a volume as small as a few microliters and detection times as 
short as a few seconds. Passage of molecules and particles 
through a nanopore causes transient disruption in the ion 
current flux through it, from which the size, concentration, 
and distribution of analytes can be deduced. [15,16] The 
electrical signal characteristics in a given analyte sample 
  
strongly depend on the analyte passing through the pore, the 
pore geometry, and the experimental conditions such as 
pH, ionic strength, applied voltage, temperature, etc.  This 
single-particle electrical sensor has been used for 
quantifying the conformational properties of proteins, [17-
23] understanding DNA transport [24-26] and detecting 
small molecules, [27,28] among many other applications. 
Previous studies have reported the ability of nanopore 
sensors to detect spherical and icosahedral viruses,[29]  virus 
capsids, [30] the masses and zeta potentials of viruses, 
[31,32] and to explore the translocation of a stiff, rod-shaped 
virus. [33]  
This ability of nanopores to detect the translocation of 
nanometer size particles motivated us to study the effect of 
an optical viral therapy on a single virus level, crucial for the 
preparation of very safe biotherapeutics. In this paper, high 
incident fs laser intensities of >100 GW/cm2, which are more 
than 105 times greater than the previous studies, have been 
used to inactivate viruses, leading to 4-log reduction in viral 
activity reduction in 1 min irradiation of ~ 2 ml sample 
volume. This result shows nearly more than four orders of 
magnitude improvement in treatment time compared to 
conventional pulsed laser viral inactivation methods.[34] 
Furthermore, we demonstrate the capability of the nanopore 
technique to precisely characterize individual viruses, 
explore how vital viral function is affected by treatment, and 
quantify how effective this label-free viral inactivation 
technique is. In light of these points, we investigate the 
effects of fs laser on inactivated ΦX174 bacteriophage, 
which has the first sequenced DNA-based phage genome 
widely used standard for viral clearance, as well as a 
surrogate for enteric human viruses. [35] By electrically 
counting virus particles in a small volume sample, we 
monitor here changes in the physical properties of treated 
virus samples. Further, we develop a statistics-based method, 
to monitor the reduction value of viruses using sequential 
measurements, and compare it with a plaque-forming assay. 
Moreover, we compare the effect of inactivation on viruses 
in an ensemble manner and at the single-virus level using 
Dynamic Light Scattering (DLS) measurement and 
nanopores, respectively. 
 
II. METHODS 
Femtosecond laser irradiation. A femtosecond laser 
based upon a Legend Elite Duo (Coherent Inc.) Ti-sapphire 
regenerative amplifier has been used as the excitation source 
in this study. The laser produces a continuous train of 35 fs 
pulses at a repetition rate of 1 kHz. The output of the second 
harmonic generation system of the laser centered at ~400 nm 
with energies up to 2.5 mJ was used to irradiate the virus 
samples. Figure 1a depicts the experimental setup. The laser 
beam with spot size ~1 cm2 was incident upon a typically 1 
cm quartz cuvette containing 2 ml of virus sample while a 
stirrer was used to homogenize the virus’s interaction with 
the laser beam. For ΦX174 sample with 1012 pfu/ml 
concentration, the laser treatment is made by exposing 250 
µl of viruses in 2 mm cuvette. Typical sample exposure times 
to the laser beam were 15 min. All experiments were carried 
out at 22 °C, and all samples were immediately stored at 4°C 
after irradiation. All experiments have been done in 
triplicate.   
 
Virus sample preparation. ΦX174 samples with 2 × 1012 
plaque forming unit (pfu) per ml concentration (Promega 
TiterMax ΦX174 Bacteriophage) in 0.05 M Sodium 
Tetraborate were stored at -80°C.  Before the experiment, 
samples were thawed to room temperature, aliquoted, and 
kept at 4°C. For diluted samples, ΦX174 spiked feed 
solutions were prepared by serial dilution in Sorenson’s 
buffer to the final concentration of approximately 106 
pfu/ml. 
 
Infectious plaque assay. To count the ΦX174 in the 
solution, samples were diluted with Sorensen’s buffer 
dilution blanks, to bring plaque to within a statistically valid 
range of 30-300 plaques per plate. Samples were assayed in 
triplicate by adding 0.1 mL of diluted sample and 0.1 mL of 
host cell suspension to a test tube containing 3 mL of molten 
(46-48 °C) ΦX174 overlay agar consist of 10 g of tryptone 
peptone (Difco), 8.5 g of agar (Difco) and 5 g of NaCl per 
liter of reagent water. Then the solution containing host cell 
and bacteriophage was vortexed and transferred to 
the ΦX174 bottom plate agar (2.5 g of NaCl, 2.5 g of KCl, 
10 g of tryptone peptone from Difco, 10 g of agar from 
Difco, and 1 mL of 1 M CaCl2 per liter of reagent grade 
water) and incubated overnight at 37 °C.  Then plaques were 
counted and the corresponding bacteriophage concentrations 
were reported as pfu/mL. Sorensen’s phosphate buffer (pH 
7.3), ΦX174 bottom plate agar, and ΦX174 overlay agar 
were purchased from Northeast Laboratory Services 
(Winslow, ME). 
 
Nanopore device fabrication and measurement. Our 
electrical detection system is composed of a nanopore 
formed in a 50-nm-thick insulating silicon nitride (SiN) 
membrane. The silicon nitride is deposited on a silicon 
substrate with 2-micron silicon dioxide previously grown on, 
which is chemically etched by potassium hydroxide (KOH) 
to obtain a freestanding membrane. The electron beam of a 
JEOL 2010F transmission electron microscope (TEM) was 
finely focused on the membrane in order to make a pore with 
controlled size. [26] The nanopore chip is then mounted in a 
fluoropolymer cell that allows electrical measurement of 
ionic current through the nanopore. The cell is filled with 0.1 
M KCl solution (16.1 mS/cm conductivity), buffered to pH 
7 using 10 mM tris. The silver-silver chloride (Ag/AgCl) 
electrodes are inserted in both cis- and trans- chambers, and 
a DC voltage is applied to flow current and drive charged 
molecules across the pore.  
 
  
Data acquisition and analysis. A Chimera VC100 
(Chimera Instruments LLC) was used for recording the ion 
current through the nanopore. Data was digitized at 4.17 
MS/s, and streamed/saved to the computer at a 1 MHz 
bandwidth. Prior to analysis, recordings were further filtered 
using a 100 kHz digital low-pass filter. To verify the pore’s 
stability, before the introduction of a virus sample to the 
nanopore, several seconds of current were collected to 
ensure that no event is detected and the baseline current is 
stable. Three key independent parameters are extracted from 
the nanopore data: the dwell time of viruses at the pore, td, 
the fractional current blockade, FI, and the inter-event 
waiting time, δt, from which virus capture rates can be 
extracted. 
 
Dynamic Light Scattering. In order to obtain information 
on the size distribution of viruses in an ensemble manner, we 
performed DLS measurement using Zetasizer Nano S90 
from Malvern Corp.  This DLS measurement is based on the 
Brownian motion of spherical particles; using the Stokes-
Einstein relation the size is calculated based on measured 
diffusion constant of particles. [36] For the size 
measurement, ΦX174 virus with 1012 pfu/ml concentration 
and ΦX174 Virion DNA (New England Biolabs) with 1,000 
µg/ml concentration, are diluted by 8-fold and 30-fold 
respectively in 10mM Tris. An aliquot of about 80 µl of the 
diluted samples is transferred to the cuvette for DLS analysis 
with the measurements done at 23 °C.   
 
 
III. RESULTS AND DISCUSSION 
Obtaining extremely high levels of viral clearance is a 
substantial step in the purification of protein-based 
therapeutics. The presence of even a single virus in the final 
drug product could be harmful to the consumer’s health. To 
prevent this, implementation of an effective viral inactivation 
strategy is crucial.  USP viral inactivation with greater than 
4-log reduction in viral infectivity would enable new 
chemical free pathogen clearance technology. [34,37,38] The 
first objective of this study is to extend the work done on USP 
inactivation of viruses, using a regeneratively amplified laser 
system. We expedite the reported USP photonic inactivation 
(>1 hr) [34] to 1 min. In this study, 35 femtosecond pulsed 
laser irradiation working at ~ 400 nm is used to irradiate 2 ml 
of ΦX174 bacteriophage for different irradiation times. 
Inactivation of viruses is measured by virus infectivity assay 
and the concentrations of the original samples were 
calculated by multiplying the plate count by the dilution 
factor, reported as pfu/mL. [39] 
The final results for the viral inactivation experiments is 
reported as the Log Reduction Value (LRV) which provides 
a direct measure of viral inactivation. The LRV was 
calculated according to:  
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 Here UC is the concentration of the untreated sample and 
TC  the concentration of the treated samples exposed to the 
laser irradiation as described. Control samples consist of a 
sample with no laser exposure which was held under 
refrigeration during the experiment and another sample 
which experienced the same pipetting and stirring condition 
as treated sample but without the laser exposure. These 
control samples never differed significantly and were taken 
to check for loss of titer in the treated suspension. As 
represented in Fig.  1b more than 104 reduction values of 
ΦX174 with 106 pfu/ml concentration is achieved by 
irradiating 2 ml of virus suspension with 2.5 W femtosecond 
laser for different treatment times ranging from 1 min to 15 
min. The combination of the large laser beam diameter with 
intensified beam results in fast viral treatment which can 
overcome the need for long irradiation times, and remove 
constraints on the corresponding practical implementation. 
 
 The next goal is to precisely monitor changes implied on 
the treated virus on the single virus level. A 20 µl aliquot of 
ΦX174 with ~1012 pfu/ml is treated for 15 min exposure with 
the same laser setup. For this low volume of sample, we used 
a micro quartz cuvette with no stirring. Again, the strong 
 
FIG. 1. a) Schematic of experimental setup for photonic viral 
inactivation. The following abbreviation are used: fs: femtosecond, QC: 
quartz cuvette, BBO: Beta barium borate. b) Log Reduction Value 
(LRV) measured for ΦX174 virus with 106 pfu/ml (patterned) and six-
orders of magnitude increased concentration (solid) after USP laser 
irradiation for different exposure time. 
  
  
reduction in viral infectivity (LRV>3) was achieved for six-
orders of magnitude increased virus concentration (Fig.  1b).  
 
As shown in Fig.  2, the ΦX174 viruses are being voltage-
driven through a ~38 nm pores made of silicon nitride (SiN). 
A TEM image of the pore is shown as an inset. The pore size 
is intentionally chosen close to the virus size to slow down 
the translocations and allow for accurate measurement of the 
events. Viruses are electroosmotically driven through the 
nanopores upon application of a negative bias to the trans 
chamber. The application of voltage results in a steady-state 
countercurrent of K+ and Cl- ions across the pore, which 
produces a stable baseline open pore current, 𝐼".  When 0.5 
µL of virus sample is added to 50 µL of buffer in the cis 
chamber, passage of individual viruses through the pore 
reduces the ionic current, which results in a spike in the 
current. This volume was sufficient to generate > 2×103 
events in 10 s for good statistics in untreated sample. The 
spike contains information about single virus, which can be 
extracted using statistical analysis methods. The current is 
measured by a Chimera VC100 amplifier which streams 1 
MHz bandwidth data to a computer at a sampling rate of 4.17 
MHz, followed by application of a 100 kHz low-pass filter in 
software to reduce the high frequency noise dominated by the 
chip capacitance. 
Figure 3a shows continuous current traces obtained when 
untreated ΦX174 viruses were added to the cis chamber at 40 
mV applied voltage. Each spike corresponds to transport of a 
single virus through the ~38 nm pore. The electric signal 
represents two predominant current levels, the higher one 
corresponds to open pore current when viruses do not 
translocate through the pore, 𝐼", and the lower corresponds to 
virus-occupied level. Based on the measured open pore 
current which is 1.13 nA, the pore conductance was 
calculated as G=28.2 nS. The inset shows a magnified view 
of a randomly selected event corresponding to individual 
intact ΦX174. The translocation current, ID , which is the 
difference between the baseline current and the pulse 
minimum, depends on pore geometry and virus size. 
Knowing the nanopore diameter as 38 nm, the nanopore 
length was estimated from the open pore conductance to be  ℎ$%% = 35	𝑛𝑚. This value, thinner than the overall initial 50 
nm membrane thickness, h, was still thicker than the expected 
thickness of ℎ$%% = ℎ/3 previously found for the very 
narrow pores. [40] As shown in Fig. 3d, the mean fractional 
current blockade for untreated ΦX174 virus is measured to be 
27%. This number is consistent with the 29% blockade 
predicted by the following theoretical equation, derived in 
Supplemental material, for a 30 nm diameter spherical virus:  
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Here 𝑑 is the virus diameter, pd is the pore diameter, and 𝜎 is 
the salt conductivity which for the 100 mM KCl buffer was 
measured as 16.7 mS/cm using the conductivity meter.   
 The agreement between theoretical and experimental 
translocation ratio verifies that the untreated viruses maintain 
their shape integrity during transport through the pore. 
Additionally, a 1-D drift-diffusion model can be used to 
describe the dwell time distribution of virus translocation 
through the nanopores. Fittings the probability density 
function (PDF) of dwell time distribution ( dt ) with the 
following equation yields two important parameters: 
diffusion constant of viruses inside the nanopore, poreD , and 
their drift velocity, dv .  
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Application of this equation, which is based on the 
assumption of barrier-free transport, [41] for the untreated 
 
FIG. 2. Schematic of the nanopore setup for virus detection. Pores 
are fabricated in freestanding SiN membranes and an external bias is 
applied across the membrane to drive ΦX174 viruses, potassium ions 
(yellow dots) and chloride (red dots) ions through the pore. Inset: TEM 
image of a fabricated nanopore. (scale bar: 20 nm) 
  
viruses (Fig. 3e) yields 20.5 /poreD m sµ=  and 
410 /dv m s
-< . 
To gain insight into the virus transport kinetics through this 
nanopore, we compare the in-pore diffusion coefficient of 
viruses with a bulk diffusion coefficient, using 
Stokes−Einstein equation 
3
Bk TD
dph
=  where kB is the 
Boltzmann constant, T  the absolute temperature, h  the 
viscosity of the solution, and d the hydrodynamic diameter of 
the virion. Using DLS we measured average diameters for 
ΦX174 of ~30 nm at 23°C, and accordingly, bulkD   was 
calculated as 214 /m sµ . The result shows small reduction in 
poreD  which can be the consequence of virus-pore 
hydrodynamic interaction, as previously observed with 
protein transport through smaller pores. [42]  
Upon successful detection of untreated viruses using 
nanopores, we probed the effect of laser treatment on the 
virus sample. A time trace for translocation of laser treated 
ΦX174 with LRV>3 (Fig.  1b) is shown in Fig.  3b. There is 
a drastic change in the time trace of treated viruses compared 
to untreated one which will be explored in more detail.  
To explore the effect of laser treatment, the scatter plot of 
fractional current blockade versus dwell-time of treated and 
untreated viruses at 40 mv voltage is shown in Fig.  3c. Two 
clear groupings of events are visible noted, corresponding to 
the treated and untreated viruses which can be visually 
distinguished by drawing a line as shown in Fig.  3c. A 
histogram of fractional current blockades and dwell-time 
distributions for both treated and untreated samples at 40 mv 
along with generalized extreme value distribution fits to the 
distributions are shown in Fig. 3 d-e respectively. The 
untreated sample is centered at FI = 25.04+/-3.1 % with 
log10(td) = 2.05+/-0.36 µs and the treated sample is centered 
at FI = 10.4+/-2.7 % with log10(td) =1.3+/-0.12 µs. These two 
sets of independent parameters (FI and td) clearly show the 
effect implied on viruses by laser treatment. The FI is related 
to the size of the particle and hence a strong decrease in the 
fractional blockade yields the first important information on 
the effect of fs laser treatment, i.e., the global appearance of 
 
FIG. 3. Comparison of pre-treatment and post-treatment of ΦX174 virus with a pulsed (35 fs) 800&400 nm laser with an average power of 2.5 W for15 
min. a,b) Continuous ion current traces collected using a 40 mv applied voltage low-pass filtered to 100 kHz, Inset: Zoomed=in portion of selected 
representative events. c) Scatter plot of fractional current blockade percentage, FI (%) at 40 mV (0.1 M KCl, 20°C) vs dwell time, td.  d) Histograms of 
fractional current blockade at 40 mv showing decrease in FI (%) after laser treatment. e) Histograms of dwell time at 40 mv voltage demonstrates faster 
translocation of treated viruses through the pore.	
  
the non-enveloped ΦX174 virus does not remains intact after 
treatment which is in agreement with previously established 
data. [6]  
  Interestingly using the capability of our label-free 
resistive pulse technique, one can monitor the inactivation of 
viruses by looking for presence of intact viruses in the 
solution with high sensitivity. One simple model is to 
consider an ellipse in the scatter plot of untreated events 
centered at the average value of fractional current in y 
direction and the average of log10(td) in x direction. The semi-
minor and semi-major axis radius of this ellipse is equal to 
three times the standard deviation of the FI and log10(td) of 
untreated events, respectively. (Fig.  4a). The standard 
deviations are obtained based on the Gaussian fits of the 
corresponding data. Counting the number of the treated (red) 
data points in the black ellipse gives us a rough estimate of 
the number of intact viruses in the treated sample, n. The 
number of points in untreated and treated scatter plot is 2,723 
and 2,564, respectively. The ratio of the n to the total number 
of red data points of the treated sample, N , gives us an 
estimation of the survival fraction (r)  
 
I
T
f nr
f N
=  
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where fI and fT are the capture probabilities of intact and 
treated virus. In our case by assuming these probabilities to 
be equal, the survival fraction is approximately 0.02. This 
quantity can provide a simple method for rapidly estimating 
the efficiency of the inactivation technique. 
 
A more precise way to estimate the r using nanopore data 
is to determine an upper bound for the number of survived 
viruses after treatment. To find the upper bound we 
developed a statistical formula that made use of a probability 
distribution function derived from Fig. 3d. The first step is to 
estimate the probability of finding a translocation event of the 
treated sample with a distinguishing feature Tx  inside the 
untreated sample region with Ux . In a simplest case Tx  and 
Ux  can be any feature which separates the two populations; 
in our case it can be fractional current blockade, dwell time 
or any other combination of these two. For example if we 
consider these one dimensional scaler as the fractional current 
blockade, in our case there is a big separation between the 
mean of untreated events, Ux , and treated ones, Tx , so that 
T Ux x< . Some of the viruses in the treated sample could be 
intact. We can quantify this possibility by considering the 
probability ( )I TP x  that an untreated virus has a value of the 
feature as low as Tx , which is the cumulative distribution 
function for the untreated sample: ( ) ( )I T U TP x CDF x= . 
Thus, for the treated data points that are far away from the 
untreated events, the result would be zero while for the ones 
which has overlap, the result is more than zero. By assuming 
all untreated viruses are intact, we can consider a threshold, 
ε, on the probability PI, and using a Heaviside step function, 
θ, we  decide if an event can be counted as an intact virus (if 
( )TIP x e³ ) or not (if ( )TIP x e< ). So for applying this 
threshold on all events, we can define a function ρε as 
equation 5 which is a sum on all treated data points 
normalized by the number of treated events, N. 
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So after treatment, there is ρε×N number of events in the 
treated sample which have the possibility bigger than ε to be 
counted as the intact viruses. This count can be written as 
 
( )(1 )N n N n qe er e´ = ´ - + - ´  (6) 
 
Where n in the first part is the actual number of intact viruses 
in the treated sample, and qe is the possibility of counting a 
broken virus as an intact one in the treated sample. In this 
calculation, since 0 1qe£ £ , the r which is n/N, will be 
 
FIG. 4. a) Scatter plot of fractional blockade of untreated (green) 
and treated (red) viruses versus event duration, under a driving voltage 
of 40 mV b) upper bound determination of the survival fraction, inset 
shows the zoom in portion of the graph. The minimum occurs at ε= 
0.2294. 
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  over the ε 
one can determine the upper bound for survival fraction, but 
still there is another point that we need to explore. This value 
of r has a large error bar due to the shot noise, so that the error 
in estimating n  is proportional to the n . In practice for large 
enough epsilon there will be no data points satisfying the 
condition of ( )I TP x e³ and the estimated value of ρε would 
be zero. Thus as a practical approach, we consider a cutoff 
and vary epsilon from 0 to the maximal value at which 
5Ner ´ ³ , where 5 is an arbitrary threshold that controls 
how accurate this method is. As shown in Fig. 4b in our case, 
rmax can be estimated as 2.5´10-3 which is similar to the 
inverse of the reduction value ~103 reported using infectivity 
assays (Fig.  1b). So these data show that the proposed 
formulation makes it possible to determine the inactivation 
efficiency using the nanopore method; while in contrast to the 
conventional infectivity assays, nanopore technique is 
capable of probing small damages to the viruses in linear base 
with high precision. 
 
Generally the electrophoretic driving force and 
electroosmotic flow are the main effects that govern a 
particle’s motion in a nanopore [43]. The first one originates 
from the force exerted to the charged nanoparticle in an 
electric field and the second one is due to the viscous drag by 
the fluid flowing through the charged nanopore in response 
to the applied voltage. Combining the equations for 
electrophoretic and electroosmotic transport yields an 
effective virus velocity v in an external electric field E inside 
the pore as [44] 
 
( )virus poreEv e z zh= -  
(7) 
 
Where z  is zeta potential, η and ε are the viscosity and 
permittivity of the electrolyte.  For our negatively charged 
viruses attempting to translocate through the nanopore with 
negative surface charge, these two forces oppose each other 
and the relative magnitudes of the forces determines the 
direction and duration of translocations [45].  
In our study, electroosmotic flow is a dominant factor, and 
therefore, the difference in membrane and viruses surface 
charge plays a dominant role on capture and transport. As 
shown in Fig.  3e, the dwell time of most of the events in the 
treated sample are <90 µs, while untreated viruses have much 
longer dwell times. In addition, upon treatment, the dwell 
time distribution narrows substantially and the fractional 
current blockades are reduced, which can be attributed to a 
morphological change in the virus sample.  
 
To further examine the impact of fs laser on virus 
conformation, we employed DLS to characterize changes in 
the radius of ΦX174 viruses and its DNA caused by laser 
treatment. The DLS measured the average diameter of the 
untreated viruses 30.9±2.3 nm (Fig.  5a), which is in 
agreement with the ΦX174 size.[46] DLS data entails two 
useful pieces of information: first it shows that the laser-
treated sample no longer possesses a monomodal size 
distribution and a second peak is observed at 458±56 nm 
which will be discussed shortly. Another important piece of 
information can be obtained from the intersection of the 
correlation curve on the y-axis of the correlogram. This y-
intercept is related to the signal-to-noise ratio (SNR) of the 
measured sample. As shown in Fig. 5b the correlation 
coefficient for the treated ΦX174 viruses has lower y-
intercept of 0.4 compared to the untreated one which is ~0.85. 
The lower y-intercept in the treated sample can be attributed 
to the concentration variations in this sample and presence of 
458 nm particles. This concentration variation can also be 
 
FIG. 5. a) DLS size distribution obtained from b) Quasi-elastic light scattering intensity autocorrelation function or correlogram of ΦX174 virus 
before (untreated) and after irradiation (treated) with IR& blue 35 fs laser pulses for 30 min (average laser power 2.5 W) c) inter-event waiting time 
obtained from nanopore measurement of the data in Fig.  3 at 40 mv applied bias, fitted by an exponential function. d) Size distribution e) Correlogram of 
ΦX174 viral DNA. Laser irradiation conditions were identical to (a,b). 
  
explored by nanopore measurements. In case of the nanopore 
measurements, the waiting time between two successive 
events (δt) is inversely proportional to the concentration of 
the detectable particles. An exponential fit to the waiting time 
data (Fig. 5c), indicates that capture rate of the viruses has 
decreased by more than one order of magnitude after laser 
treatment at the same voltage bias (40 mV). Capture rates for 
untreated and treated samples were 52±0.87 s-1 and 3.49±0.13 
s-1 respectively.  
  Particles of the second mode in the DLS data of ΦX174 
viruses have a hydrodynamic radius that is too large to be 
detected with our 38 nm nanopore. To investigate the second 
peak, we performed DLS measurement of ΦX174 virion 
DNA, the single-stranded viral DNA isolated from purified 
phage by phenol extraction (New England Biolabs). This 
measurement indicates weather the second peak is a signature 
of free DNA ejected from virus under photonic exposure. The 
DLS measured average diameter of the untreated phenol-
extracted DNA was 113.5±30 nm. A part of this variation 
may be attributed to ~ 15% of the phenol-extracted DNA 
molecules not being in circular form. The radius of gyration, 
Rg and hydrodynamic radius, Rh. of free ΦX174 DNA 
polymer can be estimated from the known persistence length  
 
2
6
c
g
P LR =  
(8) 
 
where P is persistence length and Lc is contour length. [47-
49] For ΦX174 DNA with 5386 nucleotides and the 
persistence length ~4.6 nm for DNA, [50]  the Rg and Rh can 
be estimated as 72 nm and 45.6 nm, respectively. [41,51] So 
the corresponding hydrodynamic diameter is approximately  
91 nm which is consistent with the peak in DLS measurement 
of untreated DNA.   Interestingly, DLS data of laser exposed 
DNA (Fig. 5d), still contains this peak which argues against 
complete agglomeration of single-stranded DNA due to laser 
exposure. Also, as the correlogram of the DNA (Fig. 5e) 
shows there is little difference in the time autocorrelation 
function between exposed and unexposed DNA samples. Our 
observations indicate that the 458 nm peak observed in laser-
treated ΦX174 viruses sample is not from the presence of free 
single-stranded DNA.  
Based on our data after laser treatment there are three 
possible morphology changes that can happen to ΦX174 
viruses: (i) fragmentation to small pieces, (ii) perforation of 
viruses that leads to DNA expulsion with a small associated 
change in the virus shell, and (iii) agglomeration of viral 
particles (Fig. 6). Nanopore data can be used to evaluate each 
of the possibilities. The fact that the fractional current 
blockade decreases after treatment, suggests that the particle 
diameter gets smaller upon laser exposure. Also if we neglect 
possible changes in the zeta potential of the viruses, the 
smaller viruses will translocate faster consistent with the 
observation of a shorter dwell times in the treated sample. 
Therefore, the current blockade and the dwell time both point 
to detection of entities smaller than the original viruses, and 
support the hypothesis of virus perforation. At the same time, 
the nanopore capture rate suggests that viruses for the most 
part have been fragmented to small pieces not detectable by 
the nanopore conductance.   
Neither DLS nor nanopore data don’t suggest extensive 
virus agglomeration. Since the differential scattering cross-
section for elastic scattering in the Rayleigh regime is 
proportional to the 6th power of the particle radius with given 
dielectric properties, DLS may be expected to be sensitive to 
agglomeration or presence of larger particle species. 
Additionally, significant agglomeration is expected to lead to 
a higher intensity at second diffraction mode which is not 
observed. Also in nanopore data, significant agglomeration of 
viruses can block the pore which leads to long lasting dwell 
times in contrast to what is observed in our experiments. So 
taken together, our data suggest that a small fraction of 
viruses (7%) get perforated, while a negligible fraction (< 10-
3% based on Rayleigh scattering assumption) get 
agglomerated, and the remaining largest fraction of the 
viruses (93%) are fragmented.  
While DLS provides an ensemble averaged estimate of the 
particle size distribution, it does not provide information at 
the single particle level. Our experiments suggest nanopore 
single-particle conductance measurements to be helpful in 
detecting intact viruses in small-volume samples (∼0.5 µl) to 
characterize morphological changes caused by laser 
treatment and inactivation.  
 
IV. CONCLUSION 
 The ultrashort pulsed laser technology presented here can 
be readily used for the rapid and effective disinfection of 
viruses in a label free manner. The application of this 
technology to the disinfection of viruses can lead to some 
changes in the viruses which needs to be monitored with high 
precision. Nanopore technique allowed us to detect intact 
viruses and monitor the effect of fs laser on a model virus in 
a single molecule level. Analysis of changes in the ionic 
current through the nanopore provides information about size 
and physical properties of viruses before and after laser 
treatment. To the best of our knowledge, this is the first time 
 
FIG. 6. Schematic of the possible effect of the fs laser treatment on 
ΦX174 virus. 
  
that nanopores have been used to monitor changes induced by 
an inactivation method in viruses.  
Our data is a promising step towards developing a label-free 
detection technique that can also be used as an effective 
method for monitoring the survival fraction of viruses using 
low sample volume, high precision and fast assay time.  
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